Investors
We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.
Third Quarter 2025
Third quarter 2025 results will be reviewed by management during a live audio webcast with the financial community on October 24, 2025. The presentation will be followed by a Q&A session.
Press Releases
Upcoming Events
3Nov
Berenberg Pharma CFO Call Series 2025
16:30 - 17:30 CET (Virtual)
Conferences
24Oct
Third Quarter 2025
Third quarter 2025 results will be reviewed by management during a live audio webcast with the financial community on October 24, 2025. The presentation will be followed by a Q&A session.
14:30 - 16:00 CET (8:30am – 10am EDT)
Quarterly results
10Nov
Guggenheim’s 2nd Annual Healthcare Innovation Conference
10:00 - 17:00 EST (Boston)
Conferences
30th Consecutive Year of Dividend Increase
Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Contact Our Investor Relations Team
For general inquiries
Please contact the switchboard, +33 (0)1 53 77 40 00